Related Experiment Video
Updated: May 2, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
High risk and rapid appearance of multidrug resistance during tuberculosis treatment in Moldova
Helen E Jenkins1, Valeriu Crudu, Viorel Soltan
1Boston, MA.
Abstract:
Multidrug-resistant tuberculosis (MDR-TB) is a serious problem in the former Soviet Union and may appear during TB treatment. We aimed to estimate the prevalence of, timing of and factors associated with MDR-TB diagnosis during TB treatment in Moldova, which was part of the former Soviet Union. We analysed data on 3 754 confirmed non-MDR-TB cases (between January 1, 2007 and December 31, 2010) in the Moldovan TB surveillance database, where patients provided sputum specimens for drug-susceptibility testing, multiple times, during treatment. We estimated the percentage of individuals with confirmed baseline non-MDR-TB that were diagnosed with MDR-TB during treatment, documented the time at which MDR-TB was diagnosed, and used a failure-time model to identify factors associated with MDR-TB diagnosis. Between 7.2% and 9.2% of initially non-MDR-TB cases were diagnosed with MDR-TB during treatment. Half of these MDR-TB diagnoses occurred with 3 months of the initial diagnosis. An increased MDR-TB risk during treatment was associated with baseline resistance to first-line TB drugs (linear increase in risk per additional drug), previous incarceration and HIV co-infection. MDR can appear rapidly during TB treatment. Policy considerations should emphasise management during early treatment by increasing ambulatory TB treatment to prevent nosocomial transmission, and ensuring universal rapid diagnostics access to prevent acquisition and transmission of drug resistance.
Insights
Multidrug-resistant tuberculosis (MDR-TB) can develop during treatment, with 7.2–9.2% of cases diagnosed after initial non-MDR-TB confirmation. Rapid MDR-TB diagnosis is crucial, as half occur within 3 months.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge, particularly in regions like the former Soviet Union.
- MDR-TB can emerge during the course of standard tuberculosis (TB) treatment, complicating patient management and increasing transmission risk.
Purpose of the Study:
- To determine the prevalence and timing of MDR-TB diagnosis among patients initially treated for non-MDR-TB in Moldova.
- To identify factors associated with the development of MDR-TB during TB treatment.
Main Methods:
- Analysis of a large cohort (3,754 patients) from the Moldovan TB surveillance database (2007-2010).
- Inclusion of patients with confirmed baseline non-MDR-TB who underwent serial sputum drug-susceptibility testing during treatment.
- Application of a failure-time model to assess factors linked to MDR-TB diagnosis.
Main Results:
- Between 7.2% and 9.2% of initially non-MDR-TB cases were diagnosed with MDR-TB during treatment.
- Half of these MDR-TB diagnoses occurred within three months of the initial TB diagnosis.
- Factors associated with increased MDR-TB risk during treatment included baseline resistance to first-line drugs, prior incarceration, and HIV co-infection.
Conclusions:
- MDR-TB can develop rapidly during TB treatment, highlighting the need for vigilant monitoring.
- Interventions should focus on early treatment management, including ambulatory care to prevent nosocomial spread.
- Universal access to rapid diagnostics is essential to prevent the acquisition and transmission of drug-resistant TB strains.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

